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Abstract 
This research demonstrates fluctuation of glutathione peroxidase1 (Gpx1) throughout cell cycle 
progression with significant decreased expression at mitosis of HeLa cell. This was achieved with 
western blot (WB) analysis of target proteins from each phase of synchronized cells. The 
synchronizations were performed with double thymidine (T/T) for G1/S arrest and thymidine 
followed by nocodazol (T/N) for G2/M arrest. The G1/S arrested cells were released in fresh 
medium for 3, 6, 9, 10 and 15h to obtain cell at each phase such as Gap1 (G1), synthesis (S), gap2 
(G2), mitosis (M) and gap1 (G1) phase, respectively for investigating Gpx1 expression 
throughout a complete cycle. The synchronizations were confirmed using fluorescence activated 
cell sorting (FACS) and WB analysis of phase specific markers. The fluctuations of Gpx1 
expression were verified with universal protein actin and peroxiredoxin 1 (Prx1) which are stable 
throughout the cell cycle. Intriguingly, immunoblots showed the level of Gpx1 decreases at 
mitosis phase and increased during mitotic exit to G1 phase in HeLa cells, while Prx1 protein 
level remained constant. The fractionation experiments reveal that only the cytosolic Gpx1 was 
decreased while their levels at mitochondria remain constant. The heighest levels of 
mitochondrial ROS were measured in mitosis phase with FACS analysis using Mito sox 
indicating that antioxidant activity of Gpx1 for detoxifying excessive induced endogenous 
reactive oxygen species (ROS) in the mitosis phase could be the reason for such decreasing level. 
For unfolding the molecular mechanism of such decreased expression, the Gpx1 was investigated 
at transcriptional, translational and proteosomal level. The results revealed that translational 
mechanism is involve in the decreased expression rather than transcriptional or proteosomal 
degradation at mitosis phase. This finding supports that Gpx1 involved in the cell cycle 
progression through regulation of endogenous ROS. Based on this observation further research 
could uncover their possible association with the infinitive division of a cancer cell.   
Key words: Glutathione peroxidase, Cell division, Mitosis, Reactive Oxygen species, Antioxidant 
protein. 
Introduction  
Many bioengineering approaches have been focused on engineering of artificial platform to 
explore in vitro cell adhesion, proliferation and growth of tissues with functions equivalent to 
natural (Kafi et al. 2011, 2012). However, that has not been happened to date as the generation of 
excessive ROS remains as a challenge and the issue remains unattended. Manipulation of ROS 
scavenging mechanism could be appropriate step for resolving this issue. For this, the detail 
knowledge of natural antioxidant proteins involving the ROS scavenging mechanism is required. 
Therefore, this study focusses on the role of major ROS scavenger glutathione peroxidase (Gpx) 
for uncovering their association in cell cycle progression. A numbers of antioxidant proteins, such 
as Gpx, peroxiredoxin (Prx), superoxide dismutase (SOD) etc. are involved in maintaining 
intracellular homeostasis for optimum cell growth and function (Li et al. 2013; You et al. 2015). 
This homeostasis is maintained by their up- or down-regulation and by their depletion due to the 
intra/extra cellular ROS (Ray et al. 2012; Idelchik et al. 2017). The research dealing with 
uncovering roles of antioxidant proteins during cell cycle progression attracted much attention.  
Gpx protein, known as selenoprotein, consists selenium in it’s catalytic site (Lu et al. 2009). 
Several isoform of Gpx proteins have been reported until to date (Herbette et al. 2007). Among 
these, Gpx1 is abundant isoform, which involves in scavenging endogenous ROS using electron 
provided by reduced glutathione and ubiquitously expressed in the cytoplasm and mitochondria 
of all cell types (Espinosa-Diez et al. 2015). The association of Gpx1 over expression with 
buffering oxidative stress has been proven in both in vitro cell culture and in vivo genetic mouse 
models (Borchert et al. 2006, Powers et al. 2008).. The up regulation of nuclear and cytosolic 
Gpx in differentiating cells than proliferative cell during enterocytes differentiations has been 
reported (Speckmann et al. 2011). Most of these previous studies apply exogenous stimulation for 
the over expression of Gpx to explore their specific role, which is insufficient for describing 
about status of endogenously induced Gpx expression. Therefore, monitoring of endogenous 
expressed Gpx at various phases of cell division cycle requires for exploring the possibility of 
their association in cancer cell proliferation.  
The mammalian cell follows a cascades of physiological events such as G0,, G1, S, G2 and 
Mitosis (M) for their proliferation and growth (Schorl et al. 2007). These cascades of events are 
influenced with the levels of endogenous ROS (Boonstra et al. 2004). In stressed condition, the 
excessive endogenous ROS causes disruption of several cascades of event in cell cycle 
progression (Barrera et al. 2012; Redza-Dutordoir et al. 2016). It has been reported that moderate 
level of ROS is required for G1/S transition during cell cycle Havens et al. 2006). However, 
excess level ROS disrupt such transition through activating apoptotic signaling (Circu et al. 2010). 
Thus, regulation of levels of endogenous ROS is critical event for the smooth transition of a cell 
cycle. The antioxidant proteins with ROS scavenging ability is critically requires for maintaining 
their optimum level for cell growth. There are few studies reported such scavenging mechanism 
of Gpx that plays critical role for the maintenance of cellular homeostasis for the natural cell 
function (Wang et al. 2013). The removal of endogenous ROS by the over expression of Gpx has 
been reported to induce G0/G1 arrest (Onumah et al. 2009) by decreasing cyclin D1 and 
increasing in CDK inhibitory protein p27kIPI.  However, the expression pattern of Gpx and their 
ROS depletion mechanism has not been investigated all the other stages. The Gpx expression in 
mitotic stage is critical, because cell experiences stress at this phase resulting excess ROS 
generation (Wellen et al. 2010). Thus, investigation on Gpx expression and their role in 
regulation of ROS during the mitosis phase of mammalian cell division is critically required.  
In this study, expression level of antioxidant protein throughout the cell cycle progression was 
monitored for establishing their involvement in cell growth and proliferation. We have reported 
detail expression patterns of Gpx1 protein in HeLa cell at their various stages of division cycle. 
For this, HeLa cell line was synchronized at synthesis (G1/S) and mitosis (G2/M) stages using 
double Thymidine (T/T) and Thymidine/Nocodazole (T/N) block, respectively. The 
synchronization was verified using FACS and western blotting (WB) analysis of phase specific 
proteins such as CyclinA1,Cyclin B, Cyclin D1, Cyclin E1, P27, Phosphohistone 3 (p-HH3).  The 
levels of Gpx1 protein expression were investigated using (WB) where the fluctuations are 
measured with respect to the universal protein actin. The G2/M arrested cells were released in 
fresh medium for monitoring the levels of Gpx1 with respect to their release period. The G1/S 
arrested cells were released in fresh medium for 3, 6, 9, 10, and 15h for obtaining stage specific 
endogenously expressed Gpx1. A fractionation experiment of synchronized cells was performed 
for observing the local fluctuation of Gpx1 for further confirmation of their association with stage 
specific expression. This research demonstrates the levels of Gpx1 fluctuate throughout the cell 
division cycle with a lowest intensity at mitosis phase. The research also monitored the ROS 
levels at the corresponding synthesis, mitosis and G0 arrest for establishing the relations with 
Gpx1 expressions. The lowest level of Gpx1 and the highest levels of ROS at mitosis could be 
due to antioxidant activity of Gpx1 for scavenging excessive ROS, which is required for smooth 
progression cell division cycle. 
Materials and Methods 
Chemicals and Reagent Primary antibodies used in this study are: Rabbit anti-Gpx1 (AbFrontier; 
Seoul Korea); Rabbit anti-cyclinB1 (Santa Cruz Nanotechnology); Rabbit anti-phospho-Histone 
H3(Millipore); Mouse anti-Actin; rabbit anti-peroxiredoxin (abfrontier), Cyclin A anti-rabbit 
Cycloheximide (Sigma), MG132 (Sigma). 
Cell Culture Human cervice cancer (HeLa) cells were maintained at 37oC in a 5% CO2 incubator 
and cultured in Dulbecco’s modified Eagle’s Medium (DMEM) which contain 4500 mg/L D-
glucose and L-glutamine with 10% Fetal bovine serum 1% penicillin and streptomycin. Cells 
were feeded twice in a week and sub-cultured from 90% confluent plate. Cells from third passage 
were used for experiment throughout the research. 
Cell Synchronization HeLa cells were cultured at 37oC in a 95% air, 5% CO2 and 70% humid 
condition in DMEM supplemented with 10% heat inactivated fetal bovine serum, 1% penicillin, 
and 100 mg/ml streptomycin.  Synchronization of HeLa cells at G1/S phase were carried out 
using double thymidine block (Fang et al. 1998). Briefly, cells were incubated with 2 mM 
thymidine for 18h. After washing with PBS, cells were incubated in fresh culture medium for 8h. 
Thymidine was added into the culture medium (to a final concentration 2 mM) and incubates for 
another 18h. Cells from G1/S phase were released by replacing thymidine treated culture medium 
with freshly prepared medium. The G2/M arrested cells were achieved by incubation in 
thymidine treated medium for 18h. Then, cells were washed with PBS thrice prior to the 
nocodazole (100ng/ml) for 10h. 
Sub Fractionation of Mitochondria Cytoplasm and mitochondria were isolated by fractionation 
methods using different spinning speed. Synchronized (G1/S and Mitosis arrested) Hela cells 
were homogenized in ice-cold buffer (70mM Sucrose, 1mM EDTA, 2mM Hepes, pH 7.4 220mM 
Manitol). The homogenates were centrifuged at 1000g for 10min at 40C. The resulting 
supernatant was then centrifuged at 12000g for 15 min at 40C to obtain a crude heavy 
mitochondrial pellet. The supernatant was collected as cytoplasmic fraction. The crude heavy 
mitochondrial pellet was washed once for further purification with same buffer. The pellet and 
supernatant were subjected to Western blotting analysis. 
Fluorescence Activated Cell Sorting For the analysis of cell cycle, 5×105cell/ml were washed 
twice with ice cool PBS and place overnight at 40C in 70% ethanol for fixing. The fixed cell were 
stained with 1ml sol’n containing RNase (sigma) of 50µg/ml and propidium iodide (sigma) of 
50µg/ml. Cells were incubated at least 30min at 370C and analyzed using the FACS caliber flow 
cytometer ( BD science). To check the levels of super oxides the cell expressing Mito sox was 
analyzed at the excitation of 488nm. 
Western Blot Analysis Cell lysates were prepared in lysis buffer 50mM Tris (pH 7.7)150mM 
NaCl .5% NP-40 10% glycerol1mM DTT (just add before use) Protease inhibitor (just add before 
use) DDW. Supernatant after centrifugation was recovered and protein content were quantified by 
the Bradford assay (Bio red Laboratories). Total proteins were separated by electrophoresis on 12 
and 14% SDS-polyacrylamide gels depending on size of target protein being investigated. The 
proteins were electro-blotted onto nitrocellulose membranes, probe with Primary antibody 
overnight, and re-stripped in secondary antibody after washing with PBS. 
Quantitative Real-Time PCR	 Total RNAs were isolated with Trizole Reagent and reverse 
transcribed with a reverse transcription (RT-PCR) kit (Applied Biosystems) according to 
manufactures instructions. Power SYBER Green PCR master mix (Applied Biosystems) was 
used to quantify the mRNA expressions. The primers used for quantitative RT-PCR were as 
follows: Gpx1 sense 3' CAA CCA GTT TGG GCATCA G 5' antisense   3' 
GTTCACCTCGCACTTCTCG  5'.  
Statistical Analysis All experiments were repeated at least three independent experiments and 
quantitative data were presented as mean S.E.M of triplicate deternminations from representative 
experiments. Data were analyzed using Student st-test on sigma plot 10 software and deriving the 
p-value to access the statistical significance. All western blots were done at least three to show 
reproducibility. 
Results  
Synchronization of HeLa cell for Monitoring ROS Scavenger Proteins For establishing the 
role of Gpx1 at mitotic phase initially two important ROS scavenger Gpx1 and Prx1 were 
critically monitored in the various phases of the cell cycle.  For monitoring Gpx1 and Prx1 
expression, HeLa cells were synchronized at synthesis (G1/S), mitosis (G2/M) and resting phase 
(G0), whereas unsynchronized cells were maintained in parallel as control. The synchronizations 
were confirmed with florescent activated cell sorting (FACS) (Fig. 1a) and immunoblot analysis 
of phase specific proteins, such as cyclin B and  p-HH3 as mitotic marker,, CyclinE1 as G1/S 
marker and P27 as G0 marker (Fig.1b). Western blot analysis from G1/S, G2/M, G0 and 
unsynchronized Hela cells reveals that Gpx1 protein level fluctuates during cell cycle progression, 
whereas Prx1 level was constant (Fig. 1b). The highest Gpx1 expression was observed at G1/S 
and decreases at G2/M and G0 phase. Being seleno protein, Gpx1 expression is known be 
depended on selenium supplementation (Goldson et al. 2011). The decreased expression of Gpx1 
at serum starved G0 phase is obvious since serum is the only source of selenium in the in vitro 
system (Mehdi et al. 2016). However, the decrease level of Gpx1 at G2/M was independed to 
selenium concentration since at this stage selenium level similar to G1/S. So, other hidden cause 
might be involved with the decreasing Gpx1 at G2/M phase. To uncover such hidden fact the 
detail investigation of Gpx1 expression at various periods of release from G2/M arrest was 
performed later in this work. 
Gpx1 in Cells Released from Mitosis phase The gradual Gpx1 upregulation in cell released 
from mitotic phase was investigated for unfolding the hidden fact behind the mitotic decrease. 
This was performed with monitoring Gpx1 protein in cell release from G2/M phase in a time 
dependent manner. For this, Hela cells were synchronized at G1/S phase by T/T treatment, G2/M 
phase by T/N treatment followed by the release in fresh media for 2, 5 and 10h. The 
synchronization was confirmed by FACS analysis (2a) and by detecting phase specific marker 
protein such as  cyclin B and p-HH3 for G2/M, Cyclin E1 for G1/S, Cyclin D1 for G1 and Cyclin 
A1 for S phase marker (2b). Cyclin B, a well-known mitotic marker highly expressed in T/N 
blocked cells and protein levels were decreased gradually with release period from T/N block 
(Fig. 2b) (Gavet et al. 2010). p-HH3 another important mitotic marker protein was only expressed 
in T/N arrested cells (Nielsen et al. 2013).   Whereas, the lowest expression of Gpx1 measured 
from the G2/M phase and followed by gradual increased expression were noticed from cells 
released from G2/M phases (Fig. 2b). Densitometric analysis revealed that expression of Gpx1 
protein levels were 1.5 fold higher in G1/S (T/T) arrested cells compare to mitotic cells and the 
levels were continuously increased in cell released from mitosis phase. Whereas, a stable 
expression of Prx1 were observed all phases throughout the cell cycle (Fig. 2c).  This time 
dependent gradual increase of Gpx1 expression cells release from mitosis phase indicated their 
lowest expression in the G2/M phase. However, the antioxidant activity of the Gpx1 protein in 
the detoxification of endogenous ROS for the smooth transition of cell cycle could be the prime 
cause of such decrease level of Gpx1 at G2/M phase.  For establishing this, ROS scavenging 
activity correlation between the levels of Gpx1 and endogenous ROS needs to be investigated 
form the synchronized phases of the cell cycle. 
ROS Level Throughout Cell Cycle To prove the ROS scavenging activity of Gpx1, ROS levels 
was measured in synchronized HeLa cells with Mito sox using flow cytometry analyzer (Li et al. 
2011). For this, cells were released from mitotic arrest for 2 and 5h for achieving G1 and G/S 
arrest and confirm with phase specific protein cyclin B, Cyclin D1 and Cyclin E1 as presented in 
figure 3c. ROS levels measured in synchronized HeLa cells using FACS are presented in Fig 3a. 
The levels of ROS levels in mitotic cells were higher than that of G1/S cells and decreases after 
exit from mitosis phase to G1/S phase (Fig. 3a,b). This result suggested that ROS levels fluctuate 
throughout cell cycle progression reversely as does for Gpx1. In fact, their highest level at mitosis 
phase is obvious because cell experiences severe oxidative stress at this stage (Wellen et al. 2010). 
Gpx1 could be utilized in the ROS depletion mechanisms and results their decreased levels at 
mitosis phase. However, this mitotic decrease of Gpx1 was further critically investigated later in 
this work. 
Gpx1 at All Phases of Cell Cycle The mitotic decrease of Gpx1 protein was further confirmed 
with monitoring their expression at all phases of a cell cycle. For this, HeLa cells were release 
from G1/S arrest (T/T block) for 3, 6, 9, 10 and 15h for obtaining G1/S, S, G2, M and G1, 
respectively and Gpx1 expressions were monitored at each of those phases for revealing their 
fluctuations throughout the cell cycle. Western blot analysis in Figure 4b showed Gpx1 protein 
expression were decreased only at mitosis phase (10h release from T/T block) and approximately 
protein levels were 4 fold increased at G1/S arrested cells compare to G2/M arrested cells. No 
significance difference was found among other phases of the cell cycle. Synchronizations were 
confirmed by FACS (Fig. 4a) and western blot analysis of specific marker protein  p-HH3 and 
cyclin B, Cyclin D1, Cyclin E1, Cyclin A1 as stated before (Fig. 4b) (Gavet et al. 2010; Nielsen 
et al. 2013). Relative band intensity of Gpx1 signified the difference of protein level between 
mitosis and other phases of cell cycle (Fig. 4c) suggesting that Gpx1 protein levels decreases only 
at mitosis phase.  
Local Fluctuations of Gpx1 It is known that Gpx1 localizes both in the cytoplasm and 
mitochondria of a living cell (Kryukov et al. 2003; Diamond et al. 2015). Hence, investigation is 
still required to figure out whether the cytoplasmic or mitochondrial Gpx1 are involves in the 
ROS depletion mechanism and eventually responsible for the decreased level at mitosis. We 
determine localizations of Gpx1 by separations of total lysates, cytoplasm and mitochondria 
followed by immunoblot analysis. Synchronizations were confirmed by the detection of p-HH3 
and Cyclin E1 using total lysates (Fig. 5a). Cytoplasm, mitochondria and total lysates were 
isolated from G1/S and G2/M arrested cells by fractionation method and confirm by 
corresponding protein detection such as cytoplasmic protein Prx2 and mitochondrial protein Prx3. 
A constant level Gpx1 were observed in whole cell lysates, cytoplasmic and mitochondria (Fig. 
5a) at G1/S in G1/S phase (Fig. 5a).   A low level Gpx1 from total lysate and cytoplasm were 
measured from the Mitotic arrest whereas its level at mitochondria was similar to G1/S (Fig. 5a). 
This difference in Gpx1 expression was significant in cytoplasm and total lysate, whereas non-
significant in mitochondria as observed from densitometric analysis (Figure 5b). This observation 
reveals that only the cytoplasmic Gpx1 proteins are decreased at mitosis phase. The association of 
cytoplasmic Gpx1 in ROS scavenging mechanism could be the reason which could be figure out 
in future. 
Molecular mechanisms of Gpx1 fluctuations during cell cycle progression Quantitative (Q)-
RT-PCR was performed to investigate the level of Gpx1 mRNA during cell cycle progression. 
RNAs were isolated from G1/S (T/T and T/N 10h release) and mitosis (T/N) phase arrested HeLa 
cells for the Q-RT-PCR analysis. Q-RT-PCR analysis revealed that Gpx1 mRNA is abundant in 
G1/S and mitotic phase (Figure 6a). Although, Gpx1 mRNA level is abundant in both phases, but 
their protein level decreased at mitosis phase. This indicates Gpx1 protein level might be 
regulated by post transcriptional mechanism. To prove this, we investigated proteosomal 
degradaion pathway of Gpx1 protein at mitosis phase using a well-known protease inhibitor 
MG132. As shown in figure 6b, cyclinA degradation was inhibited by MG132 at mitosis phase 
however such inhibition did not occur in case of Gpx1. The relative band intensity of Gpx1 shows 
that Gpx1 does not decrease at mitosis phase by proteosomal degradation pathway (Fig.6c).  We 
also investigated the translational mechanism during mitotic exit for unfolding the mechanism 
involves behind the reduction of Gpx1 in the mitosis. For this, cyclohexamide (CHX) was used to 
inhibit translation of Gpx1 in cells released from T/N block. Gpx1 expression was inhibited in 
CHX treated cells whereas such inhibition did not occur in non-treated released cell (Fig.6d,e).. 
The results revealed that CHX successfully inhibit Gpx1 induction in T/N released cell which 
indicates that mitotic decreased Gpx1 was gradually increased in T/N released cell due to 
translational mechanism.  
We also investigated the mechanistic phenomenon behind differences in expression patterns of 
Gpx1 and Prx1 proteins regardless of their antioxidant activity. For this, we investigated the turn-
over rate of both the antioxidant protein Gpx1 and Prx1 in Hela cells using translation inhibitor 
CHX for various time period. As our expectation, result reveals that CHX was able to inhibit 
Gpx1expression within 6h where as Prx1 protein expression was stable (Fig.6f,g). This result 
suggested that turn-over rate of Gpx1 is shorter than Prx1, which is responsible for the variations 
in their expression pattern at mitosis phase. 
Discussion 
In this study, fluctuation of Gpx1 expression was observed throughout cell cycle progression with 
the highest level at synthesis (G1/S) which decreases as progressed towards mitosis phase (G2/M) 
and reach the lowest level at G0 phase. Initially, we assumed two reasons behind these variations 
in Gpx1 expression; first reason is the role of selenium (Se) containing serum-supplemented 
medium in the G1/S phase and second is the antioxidant activity of Gpx1 for depletion of 
excessive ROS in the mitotic phase. According to first assumption, the highest Gpx1 expression 
at G1/S was obvious because of the presence of Se in serum-supplemented growth medium and 
eventually the lowest at G0 phase because of the absence of Se serum free starving medium 
(Neve 1995).  However, this hypothesis is supporting the differences in the expression of Gpx1 
between G1/S and G2/M phase since serum-supplemented medium were both the cases. 
According to the second assumption, the decreased Gpx1 is due to their antioxidant activity for 
scavenging excessive ROS generated in the mitotic phase (Lubos et al. 2011; Hugo et al. 2018). 
In supporting either of these possibilities, further experiments were designed to confirm gradual 
upregulation of Gpx1 in cells released from G2/M arrest in a time dependent manner. This 
research reveals that Gpx1 was increased with the released period indicating that selenium 
dependent stimulated expression effect was insignificant. Therefore, the gradual increasing trend 
of Gpx1 expression with the released period indicating that their antioxidant activity is the 
principal reason behind the decreased level of Gpx1 at the G2/M phase. The activity of Gpx1 in 
mitochondrial ROS scavenging is proven phenomena describe elsewhere (Lubos et al. 2011;Ray 
et al. 2012). The oxidative stress induced superoxide radicals (O2-) is neutralized to water 
through a two-step process involving SOD in a first step and Gpx1 in the second step (Raha et al. 
2000; Li et al. 2013). Any impairment of this process results generation of hydroxyradicle (-OH) 
and peroxynitrite (ONOO-) which are also removed by Gpx1 by converting it to the lipid alcohol 
and nitrite (NO2), respectively (de-Haan et al. 2011). Thus, majority of expressed Gpx1 is 
utilized for the depletions of excessive ROS generated in the G2/M phase for the smooth 
progression of cell cycle.  
The association of ROS in the mitotic decreased level of Gpx1 was further supported by revealing 
the highest level of ROS with corresponding lowest Gpx1 at mitosis phase of a cell cycle as  
measured in this work. The fluctuations of ROS levels all through the cell cycle are natural 
phenomenon in natural cell cycle because a minimum levels of ROS is requires for the transition 
of specific cell cycle phases (Havens et al. 2006). Ibañez and coworkers observed Gpx1 is critical 
for the cell cycle progression (Ibanez et al. 2011). They observed cells are arrested at G1/S when 
cell exposed to abundant antioxidant proteins proving that the antioxidant protein needs to be at 
minimum levels for smooth transition of G2/M phase. These observations suggested that Gpx1 
fluctuation requires for cell cycle progression. Such fluctuation of Gpx1 happened through three 
different molecular mechanisms such as proteosomal degradation, transcription and translation 
(Lubos et al. 2011). An in vivo study reports that Gpx1 protein levels and activity decreased by 
translational inhibition although there was abundant transcript (Handy et al. 2009) suggesting that 
translational rather than transcriptional mechanism regulates expression pattern of Gpx1 during 
cell cycle progression. Regardless of similar antioxidant activity, expression patterns of Gpx1 and 
Prx1 are dissimilar because of their different turn-over rates. We observed Gpx1 expression turn-
over occured within 6h whereas Prx1 expression remains stable indicating the shorter turn-over 
rate of Gpx1. This short turn-over rate results the decreased level of Gpx1 expression at mitosis. 
Fractionation experiment showed that this mitotic decrease was only due to the decrease of 
cytosolic Gpx1. The mitochondrial Gpx1 remains unchanged regardless the phases of a cell cycle. 
This observation supports that mitotic decrease is only due to their utilization in scavenging ROS 
mechanism (Ighodaro et al. 2017). The mitochondrial Gpx1 indicated there accumulation and 
active participation in the oxidative stress induced ROS depletion mechanism (Handy et al. 2009). 
Therefore, post-translational uses of the Gpx1 would be the only case for the mitotic decrease. 
Previous study reported that cell employs their natural homeostasis mechanism through 
endogenously expressed catalytic proteins for maintain the adequate ROS level (Ludke et al. 
2017). It is already established that many antioxidant proteins involves with depletion 
endogenously induced ROS for the completion mitotic cell division (Waris et al. 2006; Han et al. 
2018). The decreased level of Gpx1 expressions is a clear indication of their involvement in the 
catalysis of endogenous ROS for maintaining their adequate level for a smooth progression of a 
cell cycle. Thus, Gpx1 involves in the cell division mechanism through the regulation of ROS 
level, which is critical phenomenon for the onset of mitosis phase of a cell division cycle. 
Conclusion 
This research demonstrates the fluctuations of Gpx1 protein during cell division, which is 
critically required for the maintenance of intracellular homeostasis through ROS depletion for the 
cell cycle progression. Gpx1 was remarkably decreased at the G2/M phase compare to G1/S 
phase in synchronized HeLa cell. A time dependent induction of Gpx1 was observed in cells 
released from G2/M phase.  Reduction of Gpx1 exclusively observed only at mitosis phase 
suggesting utilization of Gpx1 at mitosis phase for detoxifying excessive endogenous ROS. In 
addition, fractionation experiment was further confirmed the reduction of Gpx1 in cytosol of cells 
arrested at mitosis phase. The similar level of Gpx1 expression was observed at G1, S, G2, except 
M phase is proving their utilization with the ROS detoxifying mechanism. This observation was 
further supported with highest ROS levels as measured in this work. This research also 
demonstrates that the mitotic decrease of Gpx1 was only at cytosol, while their presence in 
mitochondria indicating their accumulation for antioxidant activity. Translational mechanism 
rather than transcriptional or proteosomal degradation is involve in this decreased expression of 
Gpx1 at mitosis phase. The mitosis phases experiences severe oxidative stress, which induced 
excess endogenous ROS mitochondria in proliferative cells like cancer cell. Therefore, the level 
of Gpx1 is critical for the maintenance of cell cycle for the generation of new cell population 
through the regulation of ROS. Further research could be focused for unveil specific mechanisms 
of Gpx1 dependent ROS regulation for exploring the possibilities of cancer cell regulation.  
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Figure legend 
Figure 1. Expression pattern of antioxidant protein throughout cell cycle 
progression (a) FACS analysis of synchronized HeLa cells. (b) Western blot analysis of 
whole cell lysates of synchronized HeLa cells. G1/S arrested HeLa cells were collected 
by double thymidine treatment (T/T), mitosis by thymidine followed by nocodazole (T/N) 
treatment and G0 phase cells were collected by serum starvation for 24 h. 
Figure 2. Glutathione peroxidase protein levels decreases at mitosis phase in Hela cells 
(a)FACS analysis of synchonized HeLa cells. (b) Western blot analysis of whole cell lysates of 
synchronized HeLa cells. Cells were synchronized at G1/S phase by double thymidine block 
(T/T), mitosis phase by thymidine followed by nocodazole block (T/N) and then cells were grown 
in fresh media for 2, 5,and 10 hour after nocodazole block (c) Densitometric analysis of Gpx1 
protein expression.  
Figure 3. Intracellular H2O2 increased at mitosis phase (a) HeLa cells expressing 
hyper-mito were arrested at mitosis by thymididne/nocodazole block and release to G1 
and G1/S phase by shaking off with fresh media for indicated time.  The levels of H2O2 
were measured by flow cytometry. The H2O2 levels were measured by quantifications of 
relative DCF intensity.  (b) Relative intensity was converted to graph. Bar indicated the 
standard error. (c)  Western blotting analysis of synchronized HeLa cells. 
Figure 4. Fluctuations of Glutathione peroxidase throughout the cell cycle progression (a) 
FACS analysis of synchronized HeLa cells (b) Immunoblot analysis of whole cell lysates of all 
G1/S, S, G2, M and G1 phase arrested HeLa cells by double thymidine block (T/T). Cells were 
grown in fresh media for 3, 6, 9, 10 and 12 hour after double thymidine treatment (c) 
Densitometric analysis of Gpx1 band intensity. **p ≤0.01% and ٭ p≤≤ 0.05%. Data represents 
means +SD of three independent experiments. 
Figure 5. Cytoplasmic Gpx1 decrease at mitosis phase. (a) Immunoblot analysis of total 
lysates, cytoplasmic and mitochondrial fractions of G1/S and mitosis arrested HeLa cells. 
Phospho histone and Cyclin E1 were detected using total lysates. (b) Densitometric analysis of 
Gpx1. Immunoblot analysis of total lysates, cytoplasmic and mitochondrial fractions collected 
from 3 days cultured HeLa cells in the presence of selenium. Densitometric analysis of Gpx1. ٭ 
p≤ 0.05% ٭٭  p≤ 0.01%. Data represents means +SD of three independent experiments. 
Figure 6. Molecular mechanisms of Gpx1 fluctuations during cell cycle progression. (a). 
mRNA level of Gpx1 was quantified by RT-PCR analysis. Total RNAs were extracted from 
double thymidine (G1/S phase) and thymidine nocodazole arrested (mitosis phase) HeLa cells. 
Total RNAs were analyzed by Q-RT-PCR analysis with normalization against 36B4 (b) HeLa 
cells were synchronized at G1/S phase by double thymidine block, Mitosis by thymidine followed 
by nocodazole block with or without MG132. Protein levels were analyzed by western blot 
analysis. Densitometric analysis of Gpx1 protein band intensity (c). (d) HeLa cells were 
synchronized in G1/S phase by double thymidine (T/T) block and mitosis phase by thymidine 
nocodazole (T/N) block and after nocodazole treatment cells were grown in fresh media for 10 hr 
with or without cycloheximide and subjected to immunoblot analysis.(e) Densitometric analysis 
of Gpx1 protein band intensity. ٭ p≤ 0.05%. Data represents means +SD of three independent 
experiments. (f)  HeLa cells were exposed to cycloheximide for 0, 2, 4, 6 hours. Western blot 
analysis of whole cell lysates of cycloheximide treated HeLa cells. (g) Cyclin A, Gpx1, and Prx1 
intensity were quantified by densitometric analysis. ٭ p≤ 0.05% level of significance showed 
between 0 and 6h CHX exposure . Data represents means +SD of three independent experiments. 
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